Results:
Tag: DCIS

April 30, 2025

Justice Department Declines Prosecution of Company That Self-Disclosed Export Control Offenses Committed by Employee

The Justice Department today announced that it has declined the prosecution of Universities Space Research Association (USRA) after it self-disclosed to the Department’s National Security Division (NSD) criminal violations of U.S. export control laws committed by its former employee, Jonathan Soong. Soong pleaded guilty to willfully violating the Export Administration Regulations (EAR) by exporting U.S. Army-developed aviation software to a university in the People’s Republic of China (PRC) that had been placed on the Commerce Department’s Entity List and was sentenced to 20 months in prison.

April 29, 2025

U.S. Attorney Announces $202 Million Settlement With Gilead Sciences For Using Speaker Programs To Pay Kickbacks To Doctors To Induce Them To Prescribe Gilead’s Drugs

Gilead Admits to Paying Hundreds of Thousands of Dollars to High Prescribers of Gilead’s HIV Drugs to Serve as Speakers at Programs and to Holding Programs at Luxury Restaurants Jay Clayton, the United States Attorney for the Southern District of New York; Naomi Gruchacz, the Special Agent in Charge of the New York Regional Office of the U.S. Department of Health and Human Services, Office of Inspector General (“HHS-OIG”); Christopher M. Silvestro, the Acting Special Agent in Charge of the Northeast Field Office of the Defense Criminal Investigative Service (“DCIS”), the law enforcement arm of the Department of Defense’s Office of Inspector General (“DOD-OIG”); and Christopher G. Raia, the Assistant Director in Charge of the New York Field Office of the Federal Bureau of Investigation (“FBI”), announced today that the U.S. has settled a civil fraud lawsuit against GILEAD SCIENCES, INC (“GILEAD”), a large pharmaceutical manufacturer, that, among other things, develops, manufactures, and sells drugs for the treatment of infectious diseases, including HIV/AIDS. The settlement resolves claims that GILEAD offered and paid kickbacks in the form of honoraria payments, meals, and travel expenses to healthcare practitioners who spoke at or attended Gilead speaker events to induce them to prescribe Stribild®, Genvoya®, Complera®, Odefsey®, Descovy®, and Biktarvy® (the “Gilead HIV Drugs”) in violation of the Anti-Kickback Statute (“AKS”) and thereby caused false claims for the Gilead HIV Drugs to be submitted to and paid by federal healthcare programs in violation of the False Claims Act.

April 25, 2025

Two former laboratory sales executives sentenced to federal prison for roles in health care kickback conspiracy

Two former laboratory sales executives were sentenced to federal prison for conspiring to violate the Anti-Kickback Statute, announced Acting U.S. Attorney Abe McGlothin, Jr.

April 22, 2025

Lawton-Area Trio Sentenced to Serve More Than 12 Years Collectively in Federal Prison for Health Care Fraud

JIMMIE MATHEWS, 41, NATHAN MATHEWS, 42, and AMBER DELGER, 55, all of the Lawton area, have been sentenced for their roles in a conspiracy to commit health care fraud, announced U.S. Attorney Robert J. Troester.

April 21, 2025

Subcontractor Pleads Guilty to Conspiracy to Bribe General Services Administration Official

A Mt. Airy, Maryland, man pled guilty to conspiring to bribe a U.S. General Services Administration (GSA) official, wire fraud in connection with an Economic Injury Disaster Loan, and possession of a machine gun with an obliterated serial number.

April 21, 2025

Operators of New Jersey Company Sentenced to Prison and Enter into Related Civil Settlement Agreement for Roles in $127 Million Health Care Fraud and Kickback Scheme

Two operators of a New Jersey marketing company were sentenced to prison for their roles in conspiracies to commit health care fraud and to pay and receive illegal kickbacks, United States Attorney Alina Habba announced.

April 21, 2025

Walgreens Agrees to Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government

The Justice Department, together with the Drug Enforcement Administration (DEA) and Department of Health and Human Services Office of Inspector General (HHS-OIG), today announced a $300 million settlement with Walgreens Boots Alliance, Walgreen Co., and various subsidiaries (collectively, Walgreens) to resolve allegations that the national chain pharmacy illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA) and then sought payment for many of those invalid prescriptions by Medicare and other federal health care programs in violation of the False Claims Act (FCA). The settlement amount is based on Walgreens’s ability to pay. Walgreens will owe the United States an additional $50 million if the company is sold, merged, or transferred prior to fiscal year 2032.

April 14, 2025

Companies Pay $1.3 Million to Resolve Allegations of False Claims Act Violations Concerning Small Business Size Representations

Marc H. Silverman, Acting United States Attorney for the District of Connecticut, today announced that Whitcraft LLC and Berkshire Manufactured Products, Inc. (collectively the “Whitcraft Companies”), have entered into a civil settlement agreement with the United States and have paid $1,317,653.44 to resolve allegations that they violated the False Claims Act when the Whitcraft Companies improperly obtained set-aside contracts reserved for small businesses that they were ineligible to receive.

April 10, 2025

Florida Pharmacy Pleads Guilty to Health Care Fraud and Agrees to Pay More than $1 Million Settlement

A Florida-based pharmacy, OHM Pharmacy Services, aka “Benzer,” aka “Auburndale,” has agreed to plead guilty to one count of health care fraud; pay restitution of $82,000; and pay $1,018,000 to resolve False Claims Act violations. According to OHM’s admissions in today’s global resolution of criminal charges and civil claims, the pharmacy dispensed Evzio, one of several naloxone products on the market indicated for use on an emergent basis in the case of opioid overdose.

April 7, 2025

Pain Management Clinic Owners and Operators Indicted on Health Care Fraud Charges

The owners and operators of a Warwick pain management clinic have been indicted by a federal grand jury on health care fraud charges for allegedly defrauding government and private health care insurers, announced Acting United States Attorney Sara Miron Bloom.